Information on EC 1.8.1.7 - glutathione-disulfide reductase

Word Map on EC 1.8.1.7
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Specify your search results
Select one or more organisms in this record:
Show additional data
Do not include text mining results
Include (text mining) results (more...)
Include results (AMENDA + additional results, but less precise; more...)


The expected taxonomic range for this enzyme is: Bacteria, Eukaryota

EC NUMBER
COMMENTARY hide
1.8.1.7
-
RECOMMENDED NAME
GeneOntology No.
glutathione-disulfide reductase
REACTION
REACTION DIAGRAM
COMMENTARY hide
ORGANISM
UNIPROT
LITERATURE
2 glutathione + NADP+ = glutathione disulfide + NADPH + H+
show the reaction diagram
REACTION TYPE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
oxidation
-
-
-
-
redox reaction
-
-
-
-
reduction
PATHWAY
BRENDA Link
KEGG Link
MetaCyc Link
Glutathione metabolism
-
-
glutathione-glutaredoxin redox reactions
-
-
glutathione-peroxide redox reactions
-
-
glutathione metabolism
-
-
SYSTEMATIC NAME
IUBMB Comments
glutathione:NADP+ oxidoreductase
A dimeric flavoprotein (FAD); activity is dependent on a redox-active disulfide in each of the active centres.
CAS REGISTRY NUMBER
COMMENTARY hide
9001-48-3
-
ORGANISM
COMMENTARY hide
LITERATURE
UNIPROT
SEQUENCE DB
SOURCE
Achromobacter starkeyi
-
-
-
Manually annotated by BRENDA team
iron-grown, AP19-3
-
-
Manually annotated by BRENDA team
iron-grown, AP19-3
-
-
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
Amphiprora kufferathii
-
-
-
Manually annotated by BRENDA team
strain 7119, filamentous cyanobacterium
-
-
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
cyanobacterium
-
-
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
toad
-
-
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
strain MH2
-
-
Manually annotated by BRENDA team
strain MH2
-
-
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
yeast, IFO 0895
-
-
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
strain 011
-
-
Manually annotated by BRENDA team
strain S33
-
-
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
L. cv. Ehimehadaka no. 1
SwissProt
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
alfalfa
-
-
Manually annotated by BRENDA team
cestode
-
-
Manually annotated by BRENDA team
no activity in Drosophila melanogaster
-
-
-
Manually annotated by BRENDA team
no activity in Trypanosoma sp.
-
-
-
Manually annotated by BRENDA team
sainfoin
-
-
Manually annotated by BRENDA team
strain ATCC 24466 and 24467
SwissProt
Manually annotated by BRENDA team
Pibocella sp.
strain MH3
-
-
Manually annotated by BRENDA team
strain MH3
-
-
Manually annotated by BRENDA team
isozymes from the cold-hardened strains GR-1H and GR-2H and noncold-hardened strains GR1NH and GR-2NH; red spruce
-
-
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
Chinese brake fern
-
-
Manually annotated by BRENDA team
Wistar
-
-
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
strain MH1
-
-
Manually annotated by BRENDA team
strain MH1
-
-
Manually annotated by BRENDA team
parasite isolated from mice, enzyme is a multifunctional thioredoxin-glutathione reductase TGR
-
-
Manually annotated by BRENDA team
Trachemys scripta elegans
-
-
Manually annotated by BRENDA team
durum wheat
-
-
Manually annotated by BRENDA team
parasitic protozoa
-
-
Manually annotated by BRENDA team
parasitic protozoa
-
-
Manually annotated by BRENDA team
cultivars EPACE-1 and 1183
-
-
Manually annotated by BRENDA team
Xanthomonas campestris pv. phaseoli
TrEMBL
Manually annotated by BRENDA team
GENERAL INFORMATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
malfunction
metabolism
physiological function
SUBSTRATE
PRODUCT                       
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
Reversibility
r=reversible
ir=irreversible
?=not specified
1,4-dihydroxy-9,10-anthraquinone + NADPH
?
show the reaction diagram
1,4-naphthoquinone + NADPH
?
show the reaction diagram
1,4-naphthoquinone + NADPH + H+
?
show the reaction diagram
1,8-dihydroxy-9,10-anthraquinone + NADPH
?
show the reaction diagram
-
-
-
-
?
2,3-dimethylquinoxaline-5,8-dione + NADPH + H+
?
show the reaction diagram
2,5-bis(aziridin-1-yl)-3,6-dimethylcyclohexa-2,5-diene-1,4-dione + NADPH
?
show the reaction diagram
-
-
-
-
?
2,5-bis(aziridin-1-yl)-3-(hydroxymethyl)-6-methylcyclohexa-2,5-diene-1,4-dione + NADPH
?
show the reaction diagram
-
-
-
-
?
2,5-bis(aziridin-1-yl)cyclohexa-2,5-diene-1,4-dione + NADPH
?
show the reaction diagram
-
-
-
-
?
2,5-bis(ethylamino)-3,6-di(aziridinyl)-1,4-benzoquinone + NADPH
?
show the reaction diagram
-
-
-
-
?
2,6-dimethyl-1,4-benzoquinone + NADPH
?
show the reaction diagram
-
-
-
-
?
2-hydroxy-1,4-naphthoquinone + NADPH
?
show the reaction diagram
-
-
-
-
?
2-hydroxy-3-methyl-1,4-naphthoquinone + NADPH
?
show the reaction diagram
-
-
-
-
?
2-methyl-1,4-naphthoquinone + NADPH
?
show the reaction diagram
-
-
-
-
?
5,5'-dithiobis(2-nitrobenzoic acid) + NADPH + H+
2-nitro-5-thiobenzoate + NADP+
show the reaction diagram
-
-
-
-
?
5,8-dihydroxy-1,4-naphthoquinone + NADPH
?
show the reaction diagram
5-hydroxy-1,4-naphthoquinone + NADPH
?
show the reaction diagram
6,7-dimethylquinoline-5,8-dione + NADPH + H+
?
show the reaction diagram
6-methylquinoline-5,8-dione + NADPH + H+
?
show the reaction diagram
7-methylquinoline-5,8-dione + NADPH + H+
?
show the reaction diagram
9,10-phenanthrene quinone + NADPH
?
show the reaction diagram
-
-
-
-
?
ajoene + NADPH
4,5,9-trithiadodeca-1,6,11-triene + NADP+
show the reaction diagram
ajoene + NADPH
4,8,9,13-tetrathiahexadeca-1,6,1,15-tetraene + NADP+
show the reaction diagram
AuCl4- + NADPH + H+
?
show the reaction diagram
-
formation of gold nanoparticles at the active site of glutathione reductase that are tightly bound through the catalytic cysteines. The nanoparticles can be removed from the glutathione reductase active site with thiol reagents such as 2-mercaptoethanol
-
-
?
bis-N-chloro-gamma-L-glutamyl derivative of GSSG + NADPH + H+
? + glutathione + NADP+
show the reaction diagram
-
-
-
-
?
diallyl trisulfide + NADPH
?
show the reaction diagram
-
-
-
-
?
diethyl [2,5-bis(aziridin-1-yl)-3,6-dioxocyclohexa-1,4-diene-1,4-diyl]biscarbamate + NADPH
?
show the reaction diagram
-
-
-
-
?
glutathione disulfide + NADH + H+
2 glutathione + NAD+
show the reaction diagram
-
-
-
?
glutathione disulfide + NADH + H+
glutathione + NAD+
show the reaction diagram
glutathione disulfide + NADPH
glutathione + NADP+
show the reaction diagram
glutathione disulfide + NADPH + H+
glutathione + NADP+
show the reaction diagram
GSSG + NADPH
glutathione + NADP+
show the reaction diagram
GSSG + NADPH + H+
glutathione + NADP+
show the reaction diagram
GSSG + NADPH + H+
GSH + NADP+
show the reaction diagram
menadione + NADPH + H+
?
show the reaction diagram
peroxynitrite + NADPH
nitrite + H2O + NADP+
show the reaction diagram
quinoline-5,8-dione + NADPH + H+
?
show the reaction diagram
quinoxaline-5,8-dione + NADPH + H+
?
show the reaction diagram
S-nitrosoglutathione + NADPH + H+
? + NADP+
show the reaction diagram
-
-
-
-
?
tetramethyl-1,4-benzoquinone + NADPH
?
show the reaction diagram
-
-
-
-
?
trimethyl-1,4-benzoquinone + NADPH
?
show the reaction diagram
-
-
-
-
?
trimethyl-aziridinyl-1,4-benzoquinone + NADPH
?
show the reaction diagram
-
-
-
-
?
trypanothione + NADPH
reduced trypanothione + NADP+
show the reaction diagram
additional information
?
-
NATURAL SUBSTRATES
NATURAL PRODUCTS
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
REVERSIBILITY
r=reversible
ir=irreversible
?=not specified
glutathione disulfide + NADPH
glutathione + NADP+
show the reaction diagram
glutathione disulfide + NADPH + H+
glutathione + NADP+
show the reaction diagram
GSSG + NADPH
glutathione + NADP+
show the reaction diagram
additional information
?
-
COFACTOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
deamino-NADPH
-
69% of the activity with NADPH
ferricyanide
-
-
flavin
additional information
-
METALS and IONS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
Cd2+
-
0.05 mM, 2fold stimulation
diphosphate
-
activates
KBr
-
below 0.1 M
KCl
-
IC50: 0.51 M
KH2PO4
-
below 0.1 M
Mn2+
-
activates
Na+
-
activates
NaBr
-
activates
NaCl
-
activates
NaF
-
below 0.1 M
NH4+
-
activates
NH4Cl
-
below 0.1 M
phosphate
selenium
-
regulates the enzyme expression pattern, enzyme contains a catalytic selenocysteine
SO42-
-
stimulates
Sodium acetate
-
activates
Sodium citrate
-
activates
Sodium phosphate
-
activates
Zn2+
-
glutathione reductase is non-competitively inhibited up to 2 mM and activated above this concentration
additional information
-
optimum ionic strength of enzyme is 50 mM Tris–HCl
INHIBITORS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
(1R(S),2R(S),3S(R),4S(R))-2,3-dihydroxycyclo-hexane-1,4-diyl dinitrate
-
non-competitive inhibition
(1R(S),2R(S),4R(S),5R(S))-2,5-dihydroxycyclo-hexane-1,4-diyl dinitrate
-
non-competitive inhibition
(1S(R),2S(R),5R(S),6R(S))-5-bromo-9-oxabicyclo[4.2.1] nonan-2-yl nitrate
-
non-competitive inhibition
(1S(R),3S(R),4S(R),6S(R))-4,6-dihydroxycyclo-hexane-1,3-diyl dinitrate
-
non-competitive inhibition
(2R(S),7R(S))-7-hydroxybicyclo[2.2.1]heptan-2-yl nitrate
-
non-competitive inhibition
(2S(R),7R(S))-7-hydroxybicyclo[2.2.1] heptan-2-yl nitrate
-
non-competitive inhibition
(9R(S))-hydroxy-1,2,3,4-tetrahydro-1,4-methano-naphthalen-2R(S)-yl nitrate
-
non-competitive inhibition
1,2-bis[methylsulfonyl]-1-[2-[chloroethyl]-2-(methylamino)carbonyl]hydrazine
-
0.05 mM, 28% inhibition
1,2-Cyclohexanedione
-
-
1,3-Bis(2-chloroethyl)-1-nitrosourea
-
significant inhibition of recombinant isoform GR1 is observed at high concentrations of 1 mM and above
1,3-bis-(2-chloroethyl) 1-nitrosourea
1,3-Bis-(2-chloroethyl)-1-nitrosourea
1,3-bis[2-chloroethyl]-2-nitrosourea
1,4-dihydroxy-9,10-anthraquinone
1,4-Naphthoquinone
1,8-dihydroxy-9,10-anthraquinone
1-(2-Chloroethyl)-3-(2-hydroxyethyl)-1-nitrosourea
-
-
1-chloro-2,4-dinitrobenzene
-
reversible
1-Fluoro-2,4-dinitrobenzene
-
reversible
1-methyl-4-(2-methyl-1,3-dioxo-2,3,5a,9a-tetrahydropyrido[3,4-b]quinoxalin-5(1H)-yl)pyridinium
-
poor inhibitor
11-(3-methyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)undecanoic acid
2,3-Butanedione
-
-
2,3-dimethylquinoxaline-5,8-dione
2,4,6-Trinitrobenzenesulfonate
2,4-dihydroxybenzylamine
-
specific inhibitor, complete inhibition at 0.001 mM
2,5-bis(aziridin-1-yl)-3,6-bis[(2-hydroxyethyl)amino]cyclohexa-2,5-diene-1,4-dione
-
-
2,5-bis(aziridin-1-yl)-3,6-dimethylcyclohexa-2,5-diene-1,4-dione
-
-
2,5-bis(aziridin-1-yl)-3-(hydroxymethyl)-6-methylcyclohexa-2,5-diene-1,4-dione
2,5-bis(aziridin-1-yl)cyclohexa-2,5-diene-1,4-dione
-
-
2,5-bis(ethylamino)-3,6-di(aziridinyl)-1,4-benzoquinone
2,6-dimethyl-1,4-benzoquinone
2-acetylamino-3-[4-(2-acetylamino-2-carboxy-ethylsulfanylthio carbonylamino)phenylthiocarbamoylsulfanyl]propionic acid
-
irreversible and selective glutathione reductase inhibitor, almost complete inhibition at 0.1 mM for 1 h, thereafter, the enzyme activity starts to return and reaches 63% of the control at the end of 8 h
2-acetylamino-3-[4-(2-acetylamino-2-carboxyethylsulfanylthiocarbonylamino)phenylthiocarbamoylsulfanyl]propionic acid
-
irreversible glutathione reductase inhibitor
2-Chloroethylisocyanate
-
-
2-Hydroxy-1,4-naphthoquinone
2-hydroxy-3-methyl-1,4-naphthoquinone
2-methyl-1,4-naphthoquinone
2-methyl-5-(1-naphthyl)-5a,9a-dihydropyrido[3,4-b]quinoxaline-1,3(2H,5H)-dione
2-methyl-5-pyridin-4-yl-5a,9a-dihydropyrido[3,4-b]quinoxaline-1,3(2H,5H)-dione
3'-hydroxy-4'-O-methylisoscutellarein 7-O-[6'''-O-acetyl-beta-D-allopyranosyl-(1->2)]-beta-D-glucopyranoside
-
-
3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-aminium
-
-
3-[5-[8-(3-methyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)octyl]-1H-tetrazol-1-yl]propanenitrile
4,5-dichloro-N-octylisothiazol-3-one
-
-
5,8-Dihydroxy-1,4-naphthoquinone
5-(1-anthryl)-2-methyl-5a,9a-dihydropyrido[3,4-b]quinoxaline-1,3(2H,5H)-dione
5-(3alpha,12alpha-dihydroxy-5-beta-cholanamido)-1,3,4-thiadiazole-2-sulfonamide
-
-
5-(3alpha-hydroxy-5-beta-cholanamido)-1,3,4-thiadiazole-2-sulfonamide
-
-
5-(4-chlorophenyl)-5a,9a-dihydropyrido[3,4-b]quinoxaline-1,3(2H,5H)-dione
5-(4-chlorophenyl)-8-fluoro-2-methyl-5a,9a-dihydropyrido[3,4-b]quinoxaline-1,3(2H,5H)-dione
5-(pentafluorophenyl)-5a,9a-dihydropyrido[3,4-b]quinoxaline-1,3(2H,5H)-dione
5-chloro-N-methylisothiazol-3-one
-
-
5-hydroxy-1,4-naphthoquinone
5-nitro-2-furoic acid
-
-
5-nitroindole
-
-
6,7-dimethylquinoline-5,8-dione
6-methylquinoline-5,8-dione
6-[2-(3-fluoromethyl)-1,4-naphthoquinolyl]hexanoic acid
6-[2-(3-methyl)-1,4-naphthoquinolyl]hexanoic acid
7-methylquinoline-5,8-dione
8-azido-5-(4-chlorophenyl)-2-methyl-5a,9a-dihydropyrido[3,4-b]quinoxaline-1,3(2H,5H)-dione
9,10-phenanthrene quinone
acetaminophen-glutathione conjugate
acylfulvene
-
reversible inhibition, less than 10% residual activity at 1.25 mM, inhibition by 1.0 or 1.25 mM acylfulvene is reduced by 30% in the presence of NDPH
AgNO3
ajoene
-
i.e. (E,Z)-4,5,9-trithiadodeca-1,6,11-triene-9-oxide, natural compound from garlic, Allium sativum, covalent inhibition, but also substrate; time- and temperature-dependent inhibition, mixed disulfide between cative site Cys58 and the inhibitor, modified enzyme shows a markedly increased oxidative activity
allyl isothiocyanate
-
-
apigenin
-
flavonone, non-competitive with both NADPH and GSSG, influence on glutathione recognition
arsenite
auranofin
-
complete inhibition of both enzyme reductase activities at 10 nM
Baicalin
-
slightly, flavone glycoside, non-competitive with both NADPH and GSSG, influence on glutathione recognition
Benzyl isothiocyanate
-
-
Benzylselenosulfate
-
-
captopril
-
20 mM, 46.6% decrease of activity
carmustine
catechin
-
slightly, catechin, non-competitive with both NADPH and GSSG, influence on glutathione recognition
cefodizime
cefotaxime
ceftazidime
-
competitive inhibition
ceftriaxone
-
competitive inhibition
cefuroxime
-
competitive inhibition
Chloramphenicol
-
competitive inhibition
chromate
chrysin
-
slightly, flavonone, non-competitive with both NADPH and GSSG, influence on glutathione recognition
cisplatin
-
0.01-0.2 mM
Cr3+
-
competitive inhibition
dantrolene
-
non-competitive inhibition
diclofenac sodium
-
competitive inhibition
diethyl dicarbonate
-
chloroplast enzyme, 100% inhibition at 4 mM, 23% inhibition at 1 mM
diethyl [2,5-bis(aziridin-1-yl)-3,6-dioxocyclohexa-1,4-diene-1,4-diyl]biscarbamate
-
-
diethyldicarbonate
-
-
Dinitrosated isomers of N,N'-bis[N(2-chloroethyl)-N-carbonyl]cysteamine
-
-
-
epicatechin
-
slightly, catechin, non-competitive with both NADPH and GSSG, influence on glutathione recognition
Epicatechin gallate
-
slightly, catechin, non-competitive with both NADPH and GSSG, influence on glutathione recognition
epigallocatechin
-
slightly, catechin, non-competitive with both NADPH and GSSG, influence on glutathione recognition
epigallocatechin gallate
-
catechin, non-competitive with both NADPH and GSSG, influence on glutathione recognition
ethyl [5-(3,5-dichlorophenyl)-1,3-dioxo-3,5,5a,9a-tetrahydropyrido[3,4-b]quinoxalin-2(1H)-yl]acetate
ethyl [5-(3-chlorophenyl)-1,3-dioxo-3,5,5a,9a-tetrahydropyrido[3,4-b]quinoxalin-2(1H)-yl]acetate
-
-
etomidate
-
competitive inhibition
fisetin
-
flavonol, non-competitive with both NADPH and GSSG, influence on glutathione recognition
gadopentetic acid
-
non-competitive inhibition
gallic acid
-
slightly
glutathione
GSH
-
With regard to GSSG as variable substrate at fixed NADPH concentration (0.1 mM), GSH is a non-competitive inhibitor. With regard to NADPH as variable substrate at fixed GSSG concentration, GSH is a non-competitive inhibitor
Haemin
-
mediates covalent cross-linking and degradation of the enzyme
hydroxymethylacylfulvene
-
irreversible inhibition, less than 10% residual activity at 1.25 mM, inhibition by 0.625 or 1.25 mM hydroxymethylacylfulvene is reduced by 45% in the presence of NDPH
hypolaetin 7-O-[6'''-O-acetyl-beta-D-allopyranosyl-(1->2)]-beta-D-glucopyranoside
-
-
Imipenem
-
competitive inhibition
iodoacetamide
iodoacetate
isoscutellarein 7-O-[6'''-O-acetyl-beta-D-allopyranosyl-(1->2)]-beta-D-glucopyranoside
-
-
K+
-
inhibitory in 0.1-1.0 M concentration range
kaempferol
-
slightly, flavonol, non-competitive with both NADPH and GSSG, influence on glutathione recognition
Ketoprofen
-
competitive inhibition
ketotifen
-
non-competitive inhibition
L-gamma-glutamyl-2-methyl-L-cysteinyl-glycine disulfide
-
competitive inhibitor
lornoxicam
-
competitive inhibition
Melarsen oxide
Melatonin
meloxicam
-
non-competitive inhibition
menadione
mercuric sulfate
-
-
monohydrated complex of cisplatin
-
0.01-0.2 mM
morin
-
slightly, flavonol, non-competitive with both NADPH and GSSG, influence on glutathione recognition
morphine
-
competitive inhibition
myricetin
-
flavonol, non-competitive with both NADPH and GSSG, influence on glutathione recognition
N,N'-Bis(trans-4-hydroxychlorohexyl)-N'-nitrosourea
-
-
-
N,N,2-trimethyl-3-(10H-phenothiazin-10-yl)propan-1-amine
-
-
N,N-dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine
-
-
N,N-dimethyl-3-(10H-phenothiazin-10-yl)propan-1-aminium
-
-
N,N-dimethyl-3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propan-1-aminium
-
-
N-(2-cyanoethyl)-9-(3-methyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)nonanamide
N-Acetylimidazole
-
-
N-Alkylmaleimide
-
-
N-ethylmaleimide
Na2S2O3
-
-
Na2SO4
-
IC50: 0.45 M
NaBr
-
above 0.2 M
NADH-X
-
-
NADPH-X
-
-
NH4+
-
inhibitory in 0.1-1.0 M concentration range
NH4Cl
-
IC50: 0.62 M
Nicotine
-
0.5 mg/kg, significant inhibition of enzymatic activity in liver (61.5%), lung (65%), heart (70.5%), stomach (72.5%), kidney (64%) and testicle (71.5%)
nifurtimox
Nitrofurantoin
nitrofurazone
-
-
Nitrogen mustard
-
-
ornidazole
-
competitive inhibition
oxaliplatin
-
0.01-0.2 mM
p-chloromercuribenzoate
p-Chloromercuriphenyl sulfonate
-
-
p-hydroxymercuribenzoate
peroxynitrite
phenethyl isothiocyanate
-
-
phenyl mercuric acetate
Phenylarsonous acid
-
-
Phenylglyoxal
Phenylmethylsulfonylfluoride
-
i.e. PMSF, chloroplast enzyme, slight inhibition
phenyramidol
-
competitive inhibition
Phosphate buffer
-
-
-
propofol
-
noncompetitive inhibition
putrescine
-
the early decrease of glutathione reductase activity in leaves treated with polyamines can be due to a direct interaction of these compounds with the enzyme
pyridoxal 5'-phosphate
-
70% inactivation, due to specific modification of an epsilon-amino group lysine residue
quercetin
-
flavonol, non-competitive with both NADPH and GSSG, influence on glutathione recognition
quinoxaline-5,8-dione
riboflavin
-
-
rifamycin
-
competitive inhibition
rutin
-
slightly, flavonol glycoside, non-competitive with both NADPH and GSSG, influence on glutathione recognition
S-(2,4-dinitrophenyl)-glutathione
-
-
Sn2+
-
non-competitive inhibition
Sodium acetate
-
IC50: 0.77 M
spermidine
-
the early decrease of glutathione reductase activity in leaves treated with polyamines can be due to a direct interaction of these compounds with the enzyme
spermine
-
the early decrease of glutathione reductase activity in leaves treated with polyamines can be due to a direct interaction of these compounds with the enzyme
sulfanylacetamide
-
competitive inhibition
sulfhydryl reagents
-
in presence but not in absence of reduced coenzyme
sulforaphane
-
-
tenoxicam
-
competitive inhibition
tetramethyl-1,4-benzoquinone
TH-302
-
TH-302 at 300 mg/kg significantly inhibits glutathione reductase activity by 60% as compared with the controls, at 3 h after the injection
trans-(1S(R),2S(R))-2-hydroxycyclohexyl nitrate
-
non-competitive inhibition
trans-(1S(R),2S(R))-2-hydroxycyclooctyl nitrate
-
non-competitive inhibition
trans-(1S(R),6S(R))-6-hydroxycyclohex-3-enyl nitrate
-
non-competitive inhibition
trans-(1S(R),8S(R),Z)-8-hydroxycyclooct-4-enyl nitrate
-
non-competitive inhibition
trans-(R(S))-2-hydroxy-1-phenylethyl nitrate
-
non-competitive inhibition
trimethyl-1,4-benzoquinone
trimethyl-aziridinyl-1,4-benzoquinone
Urea
-
activation: 0.4-0.6 M, inactivation at higher concentration
Vancomycin
-
noncompetitive inhibition
[4-(3-methyl-1,4-dioxo-1,2,3,4-tetrahydronaphthalen-2-yl)phenyl]acetic acid
[4-[3-(fluoromethyl)-1,4-dioxo-1,2,3,4-tetrahydronaphthalen-2-yl]phenyl]acetic acid
[5-(3,5-dichlorophenyl)-1,3-dioxo-3,5,5a,9a-tetrahydropyrido[3,4-b]quinoxalin-2(1H)-yl]acetic acid
[{1-phenyl-2,5-di(2-pyridyl)phosphole}AuCl]
-
gold-phosphole inhibitor, 1 nM, 50% inhibition, reversible
additional information
-
ACTIVATING COMPOUND
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
abscisic acid
-
0.1 mM, significant enhancement of activity 24 h after treatment
alpha-crystallin
-
2 mg/ml causes 37% increase in activity, 1 mg/ml causes 20% enhancement
-
amikacin
-
-
amoxicillin
-
-
ampicillin
-
leads to slight activation in vivo
cadmium
-
100 mM, 111% and 100% enhancement of enzyme activity in root tissue after 7 and 14 days, respectively
captopril
-
5-10 mM, the best enhancement (30%) is achieved using 10 mM
clindamycin
-
-
cysteine
-
redox active disulfide at the catalytic site
DL-dithiothreitol
-
0.25-4 mM, the best enhancement of activity (96.6%) is obtained by a concentration of 1 mM
doxorubicin
-
differences between drug-sensitive and drug-resistant cells, overview
FAD analogues
-
gentamycin sulfate
-
leads to slight activation in vivo
GSH
-
0.25 mM, 37% enhancement of activity
H2O2
increases enzyme activity
Lincomycin
-
-
Melatonin
NaBr
-
non-linear
NADP+
-
stimulates
NADPH
-
substrate inhibition by excess of NADPH
Nicotine
-
0.5 mg/kg, 11.8% enhancement of enzymatic activity in brain
penicillin G
-
leads to slight activation in vivo
phenanthrene
-
exposure to 0.5 microM phenanthrene results in significant increases in the levels of both enzymatic and non-enzymatic antioxidants, with the levels of total glutathione and ascorbate doubling, and the activities of GR increasing by 20fold after 72 h of exposure to PHEN
Selenite
-
4fold increase in activity in U-1256 cells, less pronounced in presence of doxorubicin, differences between drug-sensitive and drug-resistant cells, overview
Sodium acetate
-
non-linear
Sodium citrate
-
non-linear
Sodium phosphate
streptomycin sulfate
-
leads to slight activation in vivo
teicoplanin
-
leads to slight activation in vivo
Thiamphenicol
-
leads to slight activation in vivo
thioltransferase
-
1 unit, 43% enhancement of activity
-
additional information
-
KM VALUE [mM]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.8
(E)-ajoene
-
-
0.38
(Z)-ajoene
-
-
0.158 - 0.172
1,4-Naphthoquinone
0.114 - 0.71
5,5'-dithiobis(2-nitrobenzoic acid)
0.0858 - 0.413
6,7-dimethylquinoline-5,8-dione
0.4104 - 0.4208
6-methylquinoline-5,8-dione
0.224 - 0.404
7-methylquinoline-5,8-dione
11.6
bis-N,N'-(gamma-glutamylcystine)
-
-
0.16
diallyl trisulfide
-
-
0.00052 - 0.00078
FAD
0.56
ferricyanide
-
-
0.023 - 8.2
glutathione
0.0123 - 2.31
glutathione disulfide
0.25
glutathione-S-sulfonate
-
-
0.00446 - 7
GSSG
0.0312 - 0.0822
menadione
3.3
mixed disulfide of CoA and glutathione
-
-
1
mixed disulfide of coenzyme A and glutathione
-
-
0.017 - 1.12
NADH
0.03 - 0.22
NADP+
0.0015 - 0.27
NADPH
0.234 - 0.363
quinoline-5,8-dione
0.0562 - 0.0595
quinoxaline-5,8-dione
0.21 - 4.58
trypanothione
additional information
additional information
-
TURNOVER NUMBER [1/s]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.34 - 1.47
(E)-ajoene
2.6
(Z)-ajoene
Homo sapiens
-
-
0.11
1,4-dihydroxy-9,10-anthraquinone
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
1 - 1.08
1,4-Naphthoquinone
0.1
1,8-dihydroxy-9,10-anthraquinone
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
5
2,5-bis(aziridin-1-yl)cyclohexa-2,5-diene-1,4-dione
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°CpH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
1.1
2,6-dimethyl-1,4-benzoquinone
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
0.14
2-methyl-1,4-naphthoquinone
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
1.2 - 16
5,5'-dithiobis(2-nitrobenzoic acid)
7
5,8-Dihydroxy-1,4-naphthoquinone
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
5.5
5-hydroxy-1,4-naphthoquinone
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
0.08 - 0.11
6,7-dimethylquinoline-5,8-dione
0.35
6-methylquinoline-5,8-dione
0.13 - 0.39
7-methylquinoline-5,8-dione
0.22
9,10-phenanthrene quinone
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
0.16
diallyl trisulfide
Homo sapiens
-
-
0.1
diethyl [2,5-bis(aziridin-1-yl)-3,6-dioxocyclohexa-1,4-diene-1,4-diyl]biscarbamate
Plasmodium falciparum
-
kcat_Km above 0.8 1/sec*mM, pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°Ckcat above 0.1 1/sec, pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
2 - 165
glutathione disulfide
0.19 - 733.3
GSSG
0.16
menadione
32.5 - 38
NADH
37.5 - 900
NADPH
1.55 - 2.23
quinoline-5,8-dione
0.34 - 0.35
quinoxaline-5,8-dione
0.3
tetramethyl-1,4-benzoquinone
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
0.2
trimethyl-1,4-benzoquinone
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
0.16 - 101.7
trypanothione
additional information
additional information
Plasmodium falciparum
-
-
-
kcat/KM VALUE [1/mMs-1]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
3.2
1,4-dihydroxy-9,10-anthraquinone
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
11244
5.2
1,4-Naphthoquinone
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
1083
0.4
1,8-dihydroxy-9,10-anthraquinone
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
7508
0.1
2,5-bis(aziridin-1-yl)-3,6-dimethylcyclohexa-2,5-diene-1,4-dione
Plasmodium falciparum
-
kcat_Km above 0.1 1/sec*mM, pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
18751
0.25
2,5-bis(aziridin-1-yl)-3-(hydroxymethyl)-6-methylcyclohexa-2,5-diene-1,4-dione
Plasmodium falciparum
-
kcat_Km above 0.25 1/sec*mM, pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
15103
40
2,5-bis(aziridin-1-yl)cyclohexa-2,5-diene-1,4-dione
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
19328
6.5
2,6-dimethyl-1,4-benzoquinone
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
3260
1.8
2-methyl-1,4-naphthoquinone
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
1950
430
5,8-Dihydroxy-1,4-naphthoquinone
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
5918
360
5-hydroxy-1,4-naphthoquinone
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
1344
4.2
9,10-phenanthrene quinone
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
6474
0.8
diethyl [2,5-bis(aziridin-1-yl)-3,6-dioxocyclohexa-1,4-diene-1,4-diyl]biscarbamate
Plasmodium falciparum
-
kcat_Km above 0.8 1/sec*mM, pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
14415
439.8 - 4850
glutathione disulfide
973
959.3 - 16800
NADPH
5
1
tetramethyl-1,4-benzoquinone
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
7640
0.7
trimethyl-1,4-benzoquinone
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
13710
0.65
trimethyl-aziridinyl-1,4-benzoquinone
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
19377
Ki VALUE [mM]
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.0174
(1R(S),2R(S),3S(R),4S(R))-2,3-dihydroxycyclo-hexane-1,4-diyl dinitrate
-
-
0.0184
(1R(S),2R(S),4R(S),5R(S))-2,5-dihydroxycyclo-hexane-1,4-diyl dinitrate
-
-
0.0215
(1S(R),2S(R),5R(S),6R(S))-5-bromo-9-oxabicyclo[4.2.1] nonan-2-yl nitrate
-
-
0.0179
(1S(R),3S(R),4S(R),6S(R))-4,6-dihydroxycyclo-hexane-1,3-diyl dinitrate
-
-
0.0117
(2R(S),7R(S))-7-hydroxybicyclo[2.2.1]heptan-2-yl nitrate
-
-
0.0131
(2S(R),7R(S))-7-hydroxybicyclo[2.2.1] heptan-2-yl nitrate
-
-
0.0188
(9R(S))-hydroxy-1,2,3,4-tetrahydro-1,4-methano-naphthalen-2R(S)-yl nitrate
-
-
0.15
1,4-dihydroxy-9,10-anthraquinone
0.0013 - 0.0025
1,4-Naphthoquinone
0.035 - 0.09
1,8-dihydroxy-9,10-anthraquinone
0.022
1-chloro-2,4-dinitrobenzene
-
at 50% inhibition value
0.2
1-methyl-4-(2-methyl-1,3-dioxo-2,3,5a,9a-tetrahydropyrido[3,4-b]quinoxalin-5(1H)-yl)pyridinium
-
pH 6.9, 25°C
0.0032 - 0.057
11-(3-methyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)undecanoic acid
0.0005
2,4,6-trinitrobenzene-sulfonate
-
below, at 50% inhibition value, leading to oxidase activity
0.5
2,5-bis(aziridin-1-yl)-3,6-bis[(2-hydroxyethyl)amino]cyclohexa-2,5-diene-1,4-dione
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
0.03
2,5-bis(aziridin-1-yl)-3,6-dimethylcyclohexa-2,5-diene-1,4-dione
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
0.0025 - 0.012
2,5-bis(aziridin-1-yl)-3-(hydroxymethyl)-6-methylcyclohexa-2,5-diene-1,4-dione
0.002
2,5-bis(aziridin-1-yl)cyclohexa-2,5-diene-1,4-dione
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
0.5
2,5-bis(ethylamino)-3,6-di(aziridinyl)-1,4-benzoquinone
0.0028
2,6-dimethyl-1,4-benzoquinone
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
0.5
2-Hydroxy-1,4-naphthoquinone
0.5
2-hydroxy-3-methyl-1,4-naphthoquinone
-
Ki above 0.5 mM, pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
0.028 - 0.039
2-methyl-1,4-naphthoquinone
0.0005 - 0.011
2-methyl-5-(1-naphthyl)-5a,9a-dihydropyrido[3,4-b]quinoxaline-1,3(2H,5H)-dione
0.0025 - 0.015
2-methyl-5-pyridin-4-yl-5a,9a-dihydropyrido[3,4-b]quinoxaline-1,3(2H,5H)-dione
0.016 - 0.16
3-[5-[8-(3-methyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)octyl]-1H-tetrazol-1-yl]propanenitrile
0.0006
5,8-Dihydroxy-1,4-naphthoquinone
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
0.0025 - 0.2
5-(1-anthryl)-2-methyl-5a,9a-dihydropyrido[3,4-b]quinoxaline-1,3(2H,5H)-dione
0.0061
5-(3alpha,12alpha-dihydroxy-5-beta-cholanamido)-1,3,4-thiadiazole-2-sulfonamide
-
-
0.0723
5-(3alpha-hydroxy-5-beta-cholanamido)-1,3,4-thiadiazole-2-sulfonamide
-
-
0.0006 - 0.0054
5-(4-chlorophenyl)-5a,9a-dihydropyrido[3,4-b]quinoxaline-1,3(2H,5H)-dione
0.0004 - 0.0059
5-(4-chlorophenyl)-8-fluoro-2-methyl-5a,9a-dihydropyrido[3,4-b]quinoxaline-1,3(2H,5H)-dione
0.0019 - 0.0025
5-(pentafluorophenyl)-5a,9a-dihydropyrido[3,4-b]quinoxaline-1,3(2H,5H)-dione
0.00015
5-hydroxy-1,4-naphthoquinone
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
0.0014 - 0.0062
8-azido-5-(4-chlorophenyl)-2-methyl-5a,9a-dihydropyrido[3,4-b]quinoxaline-1,3(2H,5H)-dione
0.0025 - 0.012
9,10-phenanthrene quinone
2.2 - 9
arsenite
0.001 - 0.25
Cd2+
0.745
cefodizime
-
pH 8.0, 25°C
6.51
cefotaxime
-
pH 8.0, 25°C
3.59
ceftazidime
-
at 25°C, pH 8.0
3.71
ceftriaxone
-
at 25°C, pH 8.0
23.5
cefuroxime
-
at 25°C, pH 8.0
3.85
Chloramphenicol
-
at 25°C, pH 8.0
0.35
chromate
0.001 - 0.117
Cu2+
0.1116
dantrolene
-
at 25°C, pH 8.0
23.97
diclofenac sodium
-
in 100 mM Tris-HCl buffer, pH 8.0, at 25°C
0.3
diethyl [2,5-bis(aziridin-1-yl)-3,6-dioxocyclohexa-1,4-diene-1,4-diyl]biscarbamate
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
0.0066 - 0.013
ethyl [5-(3,5-dichlorophenyl)-1,3-dioxo-3,5,5a,9a-tetrahydropyrido[3,4-b]quinoxalin-2(1H)-yl]acetate
0.0093
ethyl [5-(3-chlorophenyl)-1,3-dioxo-3,5,5a,9a-tetrahydropyrido[3,4-b]quinoxalin-2(1H)-yl]acetate
-
pH 6.9, 25°C
0.0725
etomidate
-
in 100 mM Tris-HCl buffer, pH 8.0, at 25°C
0.05
FAD
-
-
0.004
FMN
-
-
28.84
gadopentetic acid
-
in 40 mM Tris-HCl buffer, pH 8.0, at 25°C
5 - 10
glutathione
7.985 - 8.506
GSH
0.00033
Hg2+
-
-
0.18
hydroxymethylacylfulvene
-
at 25°C, pH not specified in the publication
0.06
Imipenem
-
at 25°C, pH 8.0
22.14
Ketoprofen
-
in 100 mM Tris-HCl buffer, pH 8.0, at 25°C
0.0008
ketotifen
-
in 40 mM Tris-HCl buffer, pH 8.0, at 25°C
0.01464
L-gamma-glutamyl-2-methyl-L-cysteinyl-glycine disulfide
-
in 100mM in potassium phosphate, pH 7.5, temperature not specified in the publication
0.42
lornoxicam
-
in 100 mM Tris-HCl buffer, pH 8.0, at 25°C
0.0091 - 0.25
Melarsen oxide
0.0061
meloxicam
-
in 40 mM Tris-HCl buffer, pH 8.0, at 25°C
0.0165
morphine
-
in 100 mM Tris-HCl buffer, pH 8.0, at 25°C
0.0108 - 0.0227
N-(2-cyanoethyl)-9-(3-methyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)nonanamide
0.54
NADH-X
-
derivative, pH 6.8, with NADH
0.0072 - 10.17
NADP+
0.022
NADPH-X
-
derivative, pH 6.8, with NADPH
0.313 - 0.932
Ni2+
0.03 - 0.04
nifurtimox
0.001 - 0.025
Nitrofurantoin
1.1
Nitrogen mustard
-
at 50% inhibition value
28.49
ornidazole
-
at 25°C, pH 8.0
0.01
p-hydroxymercuribenzoate
-
-
0.434
phenyramidol
-
in 40 mM Tris-HCl buffer, pH 8.0, at 25°C
0.418
propofol
-
in 100 mM Tris-HCl buffer, pH 8.0, at 25°C
0.02
riboflavin
-
-
0.275
rifamycin
-
at 25°C, pH 8.0
0.03
S-(2,4-dinitrophenyl)-glutathione
-
at 50% inhibition value
0.085
sulfanylacetamide
-
at 25°C, pH 8.0
0.13
tenoxicam
-
in 100 mM Tris-HCl buffer, pH 8.0, at 25°C
0.16 - 0.25
tetramethyl-1,4-benzoquinone
0.0437
trans-(1S(R),2S(R))-2-hydroxycyclohexyl nitrate
-
-
0.0219
trans-(1S(R),2S(R))-2-hydroxycyclooctyl nitrate
-
-
0.0351
trans-(1S(R),6S(R))-6-hydroxycyclohex-3-enyl nitrate
-
-
0.0443
trans-(1S(R),8S(R),Z)-8-hydroxycyclooct-4-enyl nitrate
-
-
0.0256
trans-(R(S))-2-hydroxy-1-phenylethyl nitrate
-
-
0.0162
trimethyl-1,4-benzoquinone
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
0.009 - 0.01
trimethyl-aziridinyl-1,4-benzoquinone
15.11
Vancomycin
-
at 25°C, pH 8.0
0.0008 - 0.761
Zn2+
0.0072 - 0.014
[5-(3,5-dichlorophenyl)-1,3-dioxo-3,5,5a,9a-tetrahydropyrido[3,4-b]quinoxalin-2(1H)-yl]acetic acid
IC50 VALUE [mM]
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.00717
(1R(S),2R(S),3S(R),4S(R))-2,3-dihydroxycyclo-hexane-1,4-diyl dinitrate
Homo sapiens
-
-
0.00871
(1R(S),2R(S),4R(S),5R(S))-2,5-dihydroxycyclo-hexane-1,4-diyl dinitrate
Homo sapiens
-
-
0.011
(1S(R),2S(R),5R(S),6R(S))-5-bromo-9-oxabicyclo[4.2.1] nonan-2-yl nitrate
Homo sapiens
-
-
0.0081
(1S(R),3S(R),4S(R),6S(R))-4,6-dihydroxycyclo-hexane-1,3-diyl dinitrate
Homo sapiens
-
-
0.00681
(2R(S),7R(S))-7-hydroxybicyclo[2.2.1]heptan-2-yl nitrate
Homo sapiens
-
-
0.00713
(2S(R),7R(S))-7-hydroxybicyclo[2.2.1] heptan-2-yl nitrate
Homo sapiens
-
-
0.0103
(9R(S))-hydroxy-1,2,3,4-tetrahydro-1,4-methano-naphthalen-2R(S)-yl nitrate
Homo sapiens
-
-
0.0013 - 0.0022
1,4-Naphthoquinone
0.0035
11-(3-methyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)undecanoic acid
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
0.034 - 0.085
2,3-dimethylquinoxaline-5,8-dione
0.0024
2,5-bis(aziridin-1-yl)-3,6-bis[(2-hydroxyethyl)amino]cyclohexa-2,5-diene-1,4-dione
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
0.00004
2,5-bis(aziridin-1-yl)-3,6-dimethylcyclohexa-2,5-diene-1,4-dione
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
0.00001
2,5-bis(aziridin-1-yl)-3-(hydroxymethyl)-6-methylcyclohexa-2,5-diene-1,4-dione
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
0.00043
2,5-bis(aziridin-1-yl)cyclohexa-2,5-diene-1,4-dione
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
0.295
3'-hydroxy-4'-O-methylisoscutellarein 7-O-[6'''-O-acetyl-beta-D-allopyranosyl-(1->2)]-beta-D-glucopyranoside
Bos taurus
-
in 100 mM sodium phosphate buffer, pH 7.4, at 37°C
0.0014
3-[5-[8-(3-methyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)octyl]-1H-tetrazol-1-yl]propanenitrile
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
0.014
4,5-dichloro-N-octylisothiazol-3-one
Homo sapiens
-
cellular glutathione reductase
0.0045
5-(3alpha,12alpha-dihydroxy-5-beta-cholanamido)-1,3,4-thiadiazole-2-sulfonamide
Homo sapiens
-
-
0.0471
5-(3alpha-hydroxy-5-beta-cholanamido)-1,3,4-thiadiazole-2-sulfonamide
Homo sapiens
-
-
0.009
5-chloro-N-methylisothiazol-3-one
Homo sapiens
-
cellular glutathione reductase
0.018 - 0.025
6,7-dimethylquinoline-5,8-dione
0.009 - 0.011
6-methylquinoline-5,8-dione
0.0041 - 0.0064
6-[2-(3-fluoromethyl)-1,4-naphthoquinolyl]hexanoic acid
0.0032 - 0.0045
6-[2-(3-methyl)-1,4-naphthoquinolyl]hexanoic acid
0.013 - 0.028
7-methylquinoline-5,8-dione
0.871
acylfulvene
Saccharomyces cerevisiae
-
at 25°C, pH not specified in the publication
0.804
Al3+
Oncorhynchus mykiss
-
pH 8.0, 25°C
0.1
allyl isothiocyanate
Homo sapiens
-
25°C, 30 min preincubation
0.029
Benzyl isothiocyanate
Homo sapiens
-
25°C, 30 min preincubation
0.071
carmustine
Saccharomyces cerevisiae
-
at 25°C, pH not specified in the publication
0.027 - 0.08
Cd2+
2.476
ceftazidime
Homo sapiens
-
at 25°C, pH 8.0
2.88
ceftriaxone
Homo sapiens
-
at 25°C, pH 8.0
15.43
cefuroxime
Homo sapiens
-
at 25°C, pH 8.0
2.36
Chloramphenicol
Homo sapiens
-
at 25°C, pH 8.0
0.036
Co2+
Phaeodactylum tricornutum
-
at 30°C and pH 7.5
0.0034 - 0.082
Cu2+
0.0523
dantrolene
Homo sapiens
-
at 25°C, pH 8.0
7.265
diclofenac sodium
Homo sapiens
-
in 100 mM Tris-HCl buffer, pH 8.0, at 25°C
0.0018
diethyl [2,5-bis(aziridin-1-yl)-3,6-dioxocyclohexa-1,4-diene-1,4-diyl]biscarbamate
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
0.27
diethyldicarbonate
Setaria cervi
-
in 50 mM potassium phosphate buffer pH 7.0, at 37°C
0.0523
etomidate
Homo sapiens
-
in 100 mM Tris-HCl buffer, pH 8.0, at 25°C
0.797
Fe3+
Oncorhynchus mykiss
-
pH 8.0, 25°C
138
gadopentetic acid
Homo sapiens
-
in 40 mM Tris-HCl buffer, pH 8.0, at 25°C
0.509
Hg2+
Oncorhynchus mykiss
-
pH 8.0, 25°C
0.216
hydroxymethylacylfulvene
Saccharomyces cerevisiae
-
at 25°C, pH not specified in the publication
0.177
hypolaetin 7-O-[6'''-O-acetyl-beta-D-allopyranosyl-(1->2)]-beta-D-glucopyranoside
Bos taurus
-
in 100 mM sodium phosphate buffer, pH 7.4, at 37°C
0.03
Imipenem
Homo sapiens
-
at 25°C, pH 8.0
0.372
isoscutellarein 7-O-[6'''-O-acetyl-beta-D-allopyranosyl-(1->2)]-beta-D-glucopyranoside
Bos taurus
-
in 100 mM sodium phosphate buffer, pH 7.4, at 37°C
510
KCl
Trachemys scripta
-
IC50: 0.51 M
6.278
Ketoprofen
Homo sapiens
-
in 100 mM Tris-HCl buffer, pH 8.0, at 25°C
0.012
ketotifen
Homo sapiens
-
in 40 mM Tris-HCl buffer, pH 8.0, at 25°C
0.3
lornoxicam
Homo sapiens
-
in 100 mM Tris-HCl buffer, pH 8.0, at 25°C
0.029
meloxicam
Homo sapiens
-
in 40 mM Tris-HCl buffer, pH 8.0, at 25°C
0.0275 - 0.042
menadione
0.0128
morphine
Homo sapiens
-
in 100 mM Tris-HCl buffer, pH 8.0, at 25°C
0.0015
N-(2-cyanoethyl)-9-(3-methyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)nonanamide
Plasmodium falciparum
-
pH 7.0, 0.1 M potassium phosphate, 1 mM EDTA, 25°C
0.71
N-Acetylimidazole
Setaria cervi
-
in 50 mM potassium phosphate buffer pH 7.0, at 37°C
0.5
N-ethylmaleimide
Setaria cervi
-
in 50 mM potassium phosphate buffer pH 7.0, at 37°C
450
Na2SO4
Trachemys scripta
-
IC50: 0.45 M
550
NaCl
Trachemys scripta
-
IC50: 0.55 M
620
NH4Cl
Trachemys scripta
-
IC50: 0.62 M
0.534 - 0.8
Ni2+
19.63
ornidazole
Homo sapiens
-
at 25°C, pH 8.0
0.122
Pb2+
Oncorhynchus mykiss
-
pH 8.0, 25°C
0.05
phenethyl isothiocyanate
Homo sapiens
-
25°C, 30 min preincubation
0.99
phenyramidol
Homo sapiens
-
in 40 mM Tris-HCl buffer, pH 8.0, at 25°C
0.242
propofol
Homo sapiens
-
in 100 mM Tris-HCl buffer, pH 8.0, at 25°C
0.036 - 0.037
quinoxaline-5,8-dione
0.146
rifamycin
Homo sapiens
-
at 25°C, pH 8.0
770
Sodium acetate
Trachemys scripta
-
IC50: 0.77 M
0.59
sulfanylacetamide
Homo sapiens
-
at 25°C, pH 8.0
0.045
sulforaphane
Homo sapiens
-
25°C, 30 min preincubation
0.082
tenoxicam
Homo sapiens
-
in 100 mM Tris-HCl buffer, pH 8.0, at 25°C
0.021
trans-(1S(R),2S(R))-2-hydroxycyclohexyl nitrate
Homo sapiens
-
-
0.0142
trans-(1S(R),2S(R))-2-hydroxycyclooctyl nitrate
Homo sapiens
-
-
0.023
trans-(1S(R),6S(R))-6-hydroxycyclohex-3-enyl nitrate
Homo sapiens
-
-
0.029
trans-(1S(R),8S(R),Z)-8-hydroxycyclooct-4-enyl nitrate
Homo sapiens
-
-
0.016
trans-(R(S))-2-hydroxy-1-phenylethyl nitrate
Homo sapiens
-
-
4.83
Vancomycin
Homo sapiens
-
at 25°C, pH 8.0
0.0042 - 1
Zn2+
0.0014 - 0.0077
[4-(3-methyl-1,4-dioxo-1,2,3,4-tetrahydronaphthalen-2-yl)phenyl]acetic acid
0.002 - 0.0035
[4-[3-(fluoromethyl)-1,4-dioxo-1,2,3,4-tetrahydronaphthalen-2-yl]phenyl]acetic acid
SPECIFIC ACTIVITY [µmol/min/mg]
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
0.0097
-
hemolysate, at 25°C, pH 8.0
0.01
-
hemolysate, at 25°C, pH 8.0
0.013
-
chloroquine-resistant strains 7G8 and FCR3, crude extract
0.022
-
chloroquine-resistant strain Dd2, crude extract
0.023
-
chloroquine-sensitive strain S106, crude extract
0.03
-
brain homogenate
0.033
-
chloroquine-sensitive strain 3D7, crude extract
0.035
-
chloroquine-sensitive strain HB3, crude extract
0.0362
-
purified enzyme, at pH 7.0 and 22°C
0.039
using NADH as electron donor
0.045
using NADPH as electron donor
0.047
-
chloroquine-resistant strain K1, crude extract
0.11
-
crude liver homogenate, in 100 mM potassium phosphate buffer, pH 7.4, 4 mM EDTA, at 37°C
0.119
-
crude supernatant of anoxic enzyme
0.331
-
purified enzyme
0.418
-
crude supernatant of aerobic enzyme
0.46
-
enzyme from soluble extract, at 30°C and pH 7.5
1.07
-
in C6 glioma cells, pH and temperature not specified in the publication
1.18
Achromobacter starkeyi
-
-
1.44
-
anoxic enzyme after 109fold purification
1.5
-
enzyme from hemolysate, at pH 8.0 and 25°C
2.9
-
purified enzyme
4.9
-
purified enzyme, substrate glutathione disulfide
5.03
-
purified enzyme
5.5
-
aerobic enzyme after 109fold purification
5.63
-
in HepG2 cells, pH and temperature not specified in the publication
7.16
-
homogenate, in 50 mM potassium phosphate buffer pH 7.0, at 25°C
18.6
-
using NADPH as substrate, in 50 mM phosphate buffer at pH 7.0
20.75
-
after 2139fold purification, at 25°C, pH 8.0
23
-
2555fold purified enzyme, at 25°C, pH 8.0
28
-
after 2800fold purification, at 25°C, pH 8.0
34
-
purified enzyme, with NADH
42 - 60
-
purified enzyme
50.75
-
purified erythrocyte enzyme
62.5
-
purified enzyme from erythrocytes
73.3
-
after 161fold purification, at 30°C and pH 7.5
86.9
-
purified enzyme
96
-
purified enzyme
125
-
-
139
-
purified in vitro-synthesized enzyme, 30°C, 0.002 mM FAD
140
-
purified enzyme
145
-
purified enzyme from brain
147
-
purified enzyme from liver
185.5
-
-
193
-
purified enzyme from brain
193.3
-
-
221
-
purified enzyme
249
-
purified enzyme
262
-
purified enzyme
314
-
after 209fold purification, at pH 8.0 and 25°C
320
-
purified enzyme
334
-
recombinant additional enzyme in Escherichia coli
350
-
purified enzyme
361
-
purified enzyme
373.3
-
purified enzyme
484
purified native enzyme
505
-
purified enzyme
643
-
89.8fold purified enzyme, in 50 mM potassium phosphate buffer pH 7.0, at 25°C
additional information
pH OPTIMUM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
4.5
-
NADH + GSSG
5
-
NADH + GSSG
5 - 5.5
-
NADH + GSSG
5
-
NADH + GSSG
5.7
-
NADH + GSSG
6.5 - 7.5
-
broad pH optimum centered around pH 7.0
6.8 - 7.6
-
-
7.3
-
-
7.5
-
assay at
7.7
-
root enzyme
7.8
-
assay at
7.8 - 8.6
-
broad optimum
7.8
-
assay at
7.8 - 8.6
7.8
-
assay at
pH RANGE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
5.2 - 9
-
at pH 5.2 and 9.0 about 20% of activity maximum
6 - 11
-
-
6.1 - 9.1
-
50% of maximal activity at pH 6.1 and 9.1, root enzyme
6.3 - 9.6
-
at pH 6.3-9.6 about 50% of activity maximum
6.5 - 10
-
in 100 mM Tris-HCl buffer
6.5 - 9
-
50% activity at pH 6.5 and pH 9.0, 10% activity at pH 5.0 and pH10.0
6.6 - 10.8
6.9 - 9.2
-
pH 6.9: about 50% of activity maximum, pH 9.2: about 83% of activity maximum
7 - 11
-
pH 7: about 13% of activity maximum, pH 11: 36% of activity maximum
7 - 9.5
-
pH 7: about 40% of activity maximum, pH 9.5: about 55% of activity maximum
7.3 - 8.8
-
pH 7.3: about 65% of activity maximum, pH 8.6: about 90% of activity maximum
7.5 - 9.5
-
-
TEMPERATURE OPTIMUM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
28
Achromobacter starkeyi
-
-
45
-
exponential increase in activity up to 45°C
TEMPERATURE RANGE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
15 - 40
Achromobacter starkeyi
-
15°C: about 25% of activity maximum, 40°C: about 50% of activity maximum
25 - 37
-
increasing activity between 25°C and 37°C
31 - 54
-
49% activity at 31°C and 68% activity at 54°C
pI VALUE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
5
-
calculated from amino acid sequence
5.2
-
isoelectric focusing
7.2
-
aerobic enzyme
7.32
-
anoxic enzyme
SOURCE TISSUE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
SOURCE
-
low enzyme activity
Manually annotated by BRENDA team
-
glutathione reductase activity is significantly lower in leprosy as compared to the control group
Manually annotated by BRENDA team
-
mature kernel endosperm, 2 isoforms belonging to different developmental stages
Manually annotated by BRENDA team
-
doxorubicin-sensitive lung cancer cell line
Manually annotated by BRENDA team
-
doxorubicin-insensitive lung cancer cell line expressing the MRP multi-drug resistant protein
Manually annotated by BRENDA team
-
doxorubicin-insensitive leukemic cell line HL-60-R, a subclone of HL-60
Manually annotated by BRENDA team
-
i.e. cysticeri, recovered from peritoneal cavity of 6-8 months before inoculated female Balb/c mice
Manually annotated by BRENDA team
-
localization of the enzyme in pancreatic tissue, overview
Manually annotated by BRENDA team
-
pancreas, lower expression level than in islet cells
Manually annotated by BRENDA team
-
-
Manually annotated by BRENDA team
-
doxorubicin-sensitive lung cancer cell line
Manually annotated by BRENDA team
-
doxorubicin-insensitive lung cancer cell line expressing the MRP multi-drug resistant protein
Manually annotated by BRENDA team
additional information
LOCALIZATION
ORGANISM
UNIPROT
COMMENTARY hide
GeneOntology No.
LITERATURE
SOURCE
additional information
-
analysis of the overlapping targeting signals of dual-targeted enzyme, in vitro and in vivo import analysis, overview
-
Manually annotated by BRENDA team
PDB
SCOP
CATH
ORGANISM
UNIPROT
Bartonella henselae (strain ATCC 49882 / DSM 28221 / Houston 1)
Escherichia coli (strain K12)
Escherichia coli (strain K12)
Escherichia coli (strain K12)
Escherichia coli (strain K12)
Rhizobium meliloti (strain 1021)
Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
Streptococcus mutans serotype c (strain ATCC 700610 / UA159)
MOLECULAR WEIGHT
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
32000
-
2 * 56000 + associated polypeptide 1 * 32000, SDS-PAGE
36000
-
x * 57000 + x * 36000
37000
-
x * 57000 + x * 37000, SDS-PAGE
43000
-
2 * 43000, SDS-PAGE
49000
-
2 * 49000, SDS-PAGE
49300
2 * 50000, SDS-PAGE, 2 * 49300, MALDI-TOF mass spectrometry
50200
-
2 * 50200
51698
-
2 * 51698, sequence calculation
52500
-
2 * 52500
53400
-
2 * 53400, SDS-PAGE
53470
-
subunit, calculated from amino acid sequence
53600
-
calculated from sequence of cDNA
54000 - 56000
-
gel filtration
54000
-
2 * 54000, SDS-PAGE, gel filtration in presence of urea
54600
-
quadrupol time of flight electrospray ionization mass spectrometry
54800
-
1 * 54800, active monomeric form, SDS-PAGE
57100
-
2 * 57100, calculated for GR1 including the N-terminal His-tag
61000
-
native polyacrylamide gel electrophoresis
62000
Amphiprora kufferathii
-
native polyacrylamide gel electrophoresis
65000
-
2 * 65000, SDS-PAGE
66000
-
2 * 66000, SDS-PAGE
67000
-
liver enzyme, about
71000
Amphiprora kufferathii
-
native polyacrylamide gel electrophoresis
72000
-
2 * 72000, SDS-PAGE
94000
-
gel filtration
96000
-
apoenzyme without FAD, sedimentation equilibrium
99200
velocity sedimentation analysis
99800
-
Spirulina maxima, pore gradient gel electrophoresis, dimer, enzyme exists predominantly as tetrameric species in equilibrium with a minor dimer fraction
102000
-
gel filtration
103000
-
analytical ultracentrifugation
104000
105000
106000
-
calculation from sedimentation and diffusion coefficients
107000
108000
-
ultracentrifugation in glycerol density gradient, dimer, enzyme can also be active also as monomer
110000
116000
-
gel filtration
118000
120000
123000
-
gel filtration
125000
127000
-
gel filtration
136000
-
gel filtration
140000
-
native PAGE
145000
-
gel filtration
149000
-
native PAGE
150000
-
chloroplast enzyme, gel filtration
156000
-
gel filtration
177000
-
sedimentation equilibrium, tetramer, enzyme exists predominantly as a tetrameric species in equilibrium with a minor dimer fraction
additional information
-
-
SUBUNITS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
?
-
x * 55000, SDS-PAGE
homodimer
monomer
oligomer
tetramer
additional information
POSTTRANSLATIONAL MODIFICATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
additional information
Crystallization/COMMENTARY
ORGANISM
UNIPROT
LITERATURE
hanging drop method, form-S grown crystals from salt and form-P grown crystals from PEG-8000, X-ray analysis
-
trigonal crystals, high internal symmetry
-
binding structure of diverse FAD analogues to the apoenzyme
-
dialysis for 72 h against 1000 volumes of deionized water with 1 change
-
hanging drop vapour diffusion method
-
molecular asymmetry of crystals from deionized water and from 2 M ammonium sulfate, exact 2fold molecular axis in the dimer, form A-D, three-dimensional structure
-
structure analysis overview, ligand binding, active center
-
substrate-binding and structure analysis
-
hanging drop vapour diffusion method
-
peroxynitrite inactivated enzyme, hanging drop vapour dffusion method, 10 mg/ml protein in 120 mM ammonium sulfate, 100 mM potassium phosphate, pH 7.5, against reservoir solution containing 720 mM ammonium sulfate, 100 mM potassium phosphate, pH 8.0, 30-37°C, 5 days, storage and handling in stabilization solution containing 1 M ammonium sulfate, 100 mM potassium phosphate, pH 8.0, X-ray structure determination and analysis at 1.9 A resolution
-
purified recombinant strain K1 wild-type enzyme, enzyme is dialyzed against EDTA for 3 h, hanging drop vapour diffusion method, protein solution contains 10 mg/ml protein, mixed with an equal volume of reservoir solution containing 14% w/v PEG monomethylether 550, 70 mM NaCl, 70 mM bicine, pH 8.7-9.0, 20°C, one week, X-ray diffraction structure determination and analysis at 3.0 A resolution, molecular replacement
-
hanging drop method, crystal structure is determined at 2.40 A resolution
hanging drop vapor diffusion method, using 22% (w/v) PEG 3350, 0.1 M HEPES pH 7.2, 0.2 M NaNO3, 5 mM dithiothreitol, or beta-mercaptoethanol
-
hanging-drop method at 22°C, size of crystals varies with ammonium sulfate concentration
-
pH STABILITY
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
3
-
stable
394709
4 - 10
-
-
394770
4
-
glutathione reductase has little or no activity at pH 4.0 or lower
698440
5.6
-
30 min, stable
394745
5.8 - 8.4
-
67°C: stable, 78°C: unstable
394720
6 - 8
-
unstable below and above
394748
6.5 - 10
-
the enzyme remains stable in 100 mM Tris-HCl buffer between pH 6.5 and 10.0, the activity remains practically unchanged between pH 6.5-7.5 and decreases significantly only above pH 8.5
701146
7.3
-
optimally stable at
660339
7.4
-
optimally stable at
657570
7.5 - 9.5
-
4°C, stable
394737
7.5
-
unstable below
394737
8
-
7 days in 50 mM Tris–HCl buffer, 76.25% of initial activity
686233
TEMPERATURE STABILITY
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
0 - 4
-
there is no appreciable effect of freezing and thawing on enzyme activity for approximately 1 month
20
-
24 h, stable
30 - 35
-
the abrupt decrease in activity observed at temperatures higher than 35°C, can be associated with loss of enzyme stability beyond 30°C
30
-
reduced form of the enzyme highly unstable
37
-
8 h, stable
42.5
-
complete loss of activity above 42°C, 10 min in presence of NADPH
60 - 65
-
oxidized form stable
62
-
unstable above
67
-
pH 5.8-8.4, stable
78
-
pH 5. 8-8.4, unstable
80
-
NADP+, GSSG, glutathione and dichloroindophenol protect against thermal inactivation at 80°C
additional information
GENERAL STABILITY
ORGANISM
UNIPROT
LITERATURE
1 mM EDTA is required
-
active in the presence of imidazole up to 0.8 M, the native enzyme is resistant to digestion by trypsin or chymotrypsin
-
complete inactivation after incubation with NADH, reversible by addition of GSSG
-
complete inactivation after incubation with NADPH, reversible by addition of GSSG
concentrated solution, stable for years
crystals and amorphous protein obtained by precipitation with ammonium sulfate are stable
dichloroindophenol protects against thermal inactivation at 80°C
-
dithiothreitol stabilizes
-
FAD, no stabilization against thermal inactivation at 80°C
-
FAD, stabilizes
-
freezing denaturates
glutathione protects against thermal inactivation at 80°C
-
glutathione stabilizes chloroplast enzymes
-
glycerol stabilizes
-
GSSG protects against thermal inactivation at 80°C
-
NADP+ stabilizes
NADP+, stabilizes against thermal inactivation at 80°C
-
NADPH is not protective against induced inactivation by peroxynitrite
-
partial inactivation after incubation with ATP
-
pure enzyme heated in presence of bovine serum albumin and 0.020 mM NADPH: loss of activity beyond 30°C, significant reduction even at 0°C
-
repeated freezing and thawing, inactivation
repeated freezing and thawing, no effect
-
repeated freezing and thawing, stable
urea, activation from 0.4-0.6 M, inactivation at higher concentration
-
urea, quite stable to
OXIDATION STABILITY
ORGANISM
UNIPROT
LITERATURE
oxygen promotes enzyme aggregation by oxidation of thiols, that prevent oxidation of the enzyme
-
394725
STORAGE STABILITY
ORGANISM
UNIPROT
LITERATURE
-18°C, in the dark, 10% glycerol, 5 mM NADP+, for at least 1 year
-
-20°C, 1 year
-
-20°C, 2 years
-
-20°C, 2-3 months
Achromobacter starkeyi
-
-20°C, 20 mM potassium phosphate, pH 7.5, 1 mM EDTA, 10% glycerol, months
-
-20°C, pH 6.8, 0.05 M potassium phosphate buffer, indefinitely stable
-
-20°C, several weeks
-
-20°C, with several freeze-thawing cycles, more than 2 years, stable
-
-28°C, 50 mM phosphate buffer, a few months
-
-70°C, pH 7.0, 1 mM EDTA, 1 mM dithiothreitol, 0.020 mM FAD, 5 mM NADP+
-
0-4°C, 1 month, no appreciable effect of freezing and thawing on enzyme activity
-
0-4°C, crystals in buffer, several months
-
0°C, 6 days
-
25°C, in the dark
-
4°C, 50 mM potassium phosphate, pH 7.4, 50% loss of activity after 10 days
-
4°C, activation after storage over days, months or years
4°C, concentrated purified enzyme, 0.05% NaN3, 50 mM potassium phosphate, pH 7.4, 2 mM EDTA, 150 mM NaCl, 2 mM glutathione, quite stable
-
4°C, pH 7.5, 50 mM sodium phosphate buffer, 1 mM 2-mercaptoethanol, 1 mM EDTA
-
4°C, pure enzyme without stabilizers such as glycerol, 8 days, 25% loss of activity
-
4°C, several weeks
-
concentrated solution, years
in refrigerator, several months
-
Purification/COMMENTARY
ORGANISM
UNIPROT
LITERATURE
1714fold from liver homogenate, by ammonium sulfate fractionation, affinity chromatography, and gel filtration
-
2',5'-ADP agarose affinity chromatography and DEAE Sephadex gel filtration
-
2',5'-ADP Sepharose 4B affinity chromatography and DEAE Sepharose column chromatography
-
31250fold from erythrocyte hemolysate, by ammonium sulfate fractionation, affinity chromatography, and gel filtration
-
5000fold from brain to homogeneity in several steps, overview
-
5342fold to homogeneity from erythrocytes by hemolysis, ammonium sulfate fractionation, affinity chromatography, and gel filtration
-
647fold to homogeneity from metacystodes by ammonium sulfate fractionation, ion exchange chromatography, affinity chromatography, and gel filtration
-
amino acid sequence analysis
-
ammonium sulfate fractionation, 2',5'-ADP Sepharose 4B affinity chromatography and Sephadex G-200 gel filtration
ammonium sulfate precipitation, 2 ',5'-ADP Sepharose-4B affinity column chromatography and Sephadex G-200 gel filtration
-
ammonium sulfate precipitation, 2',5'-ADP Sepharose 4B column chromatography and Sephadex G-200 gel filtration
-
ammonium sulfate precipitation, 2ā€˜ā€˜,5ā€˜-ADP Sepharose 4B affinity column chromatography, and Sephadex G-200 gel filtration
-
ammonium sulfate precipitation, DEAE-Sepharose column chromatography, Blue-A Sepharose column chromatography, and 2',5'-ADP-Sepharose column chromatography
-
ammonium sulfate precipitation, ultrafiltration, CM-Sepharose column chromatography, DEAE-Sepharose column chromatography, GSH–Sepharose affinity column chromatography, and ADP-Sepharose affinity chromatography
-
chloroplast enzyme
-
enzyme expressed from plasmid, small and large scale
-
from erythrocyte
-
from lens and erythrocytes
-
from temperature hardened and nonhardened strains
-
heat-denaturation and Sephadex G25 gel filtration, 2',5'-ADP agarose 4B column chromatography, and PBE94 column chromatography
-
ion exchange chromatography on hydroxylapatite, LKB 8101 isoelectrofocusing column chromatography, Sephacryl S-300 column gel filtration and Matrix Red dye ligand chromatography
-
ion exchange column chromatography and gel filtration
-
large scale
-
Mono Q HR 5/5 column chromatography and 2'5'-ADP Sepharose 4B affinity chromatography
-
native enzyme from microplasmodia, 968fold in a multistep procedure
Ni-NTA affinity column chromatography
-
Ni-NTA agarose resin column chromatography
Ni2+-NTA column chromatography
-
nickel affinity column chromatography
partially
recombinant His-tagged enzyme from in-vitro expression by nickel chelate affinity chromatography
-
recombinant mutant from Escherichia coli
-
to homogeneity from brain
-
via high-level expression of recombinant enzyme in Escherichia coli
-
wild-type and recombinant from Escherichia coli
-
Cloned/COMMENTARY
ORGANISM
UNIPROT
LITERATURE
2 isoforms: DNA sequence analysis, multiple gene copies
-
construction of a genetic library, DNA and amino acid sequence determination and analysis of the enzyme encoding gene, expression in Escherichia coli
DNA sequence determination, genomic structure
Escherichia coli gene
-
expressed in Escherichia coli
expressed in Escherichia coli BL21(DE3) cells
expressed in Nicotiana tabaccum cultivar Wisconsin 38
expressed in NIH-3T3, TM-3, MSC-1, and TM-4 cells
-
expressed in Saccharomyces cerevisiae
-
expressed in Saccharomyces cerevisiae BY4741 cells
expression in Escherichia coli of a His-tagged high-level expression mutant
-
expression in Escherichia coli; expression in Escherichia coli
expression of strain K1 wild-type and mutant enzymes in Escherichia coli
-
expression of wild-type and mutant in Escherichia coli, structure modeling
-
in-vitro His-tagged enzyme expression
-
mutant enzyme glutathione reductase-trypanothine reductase, expression in Escherichia coli
-
overexpression of Saccharomyces cerevisiae Glr1 in Pichia pastoris GS115
tissue expression analysis
-
transient expression of the enzyme's targeting signal sequence fused to the green fluorescent protein, as well as GFP-holoenzyme fusion protein, targets to the chloroplasts only
-
EXPRESSION
ORGANISM
UNIPROT
LITERATURE
after treatment with methyl viologen for two weeks, there is a significant increase in the glutathione reductase activity in both wild type and transgenic plants and such an increase is greater in transgenic plants than in wild type plants
expression of isoform GR3 is induced by salt stress (35fold in shoots at 200 mM NaCl, 6fold in roots by 100 mM NaCl). In addition, the transcript level of isoform GR3 is greatly increased with salicylic acid treatment (0.1-0.2 mM)
glutathione reductase activity is generally higher in the rag2 mutant than in the wild type strain, either under hypoxic or aerobic conditions; the treatment with menadione, H2O2, or tert-butyl hydroperoxide does not increase significantly glutathione reductase activity in the wild type strain
hepatic glutathione reductase activity is significantly increased on days 4 and 10 after injection of DL-ethionine (12.5 mg/kg)
-
the expression of isoforms GR2 and GR3 but not GR1 is increased in rice roots treated with NaCl, Na+ but not Cl- or osmotic stress is involved in NaCl-induced expression of glutathione reductase in roots of rice seedlings, after 8 h treatment with NaCl (150, 200, and 300 mM), isoform GR3 expression is specifically increased, the expression of isofomr GR2 is also increased by 150 and 200 mM NaCl but not 300 mM NaCl, no significant increase due to NaCl (150, 200, and 300 mM) can be detected in the expression of isoform GR1
-
the transcript level of isoform GR3 is not significantly affected by methyl jasmonate, dehydration or heat shock stress
zinc exposure (0.01, 0.03, and 0.1 mM Zn2+ for a period of 48 h) causes a concentration-dependent reduction in glutathione reductase activity in gills, liver and brain
-
ENGINEERING
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
A18E//N21W/R22N/N101D/K105D/R319A
-
mutant enzyme shows very little activity with GSSG in micromolar range but, on increasing the GSSG concentration to 20 mM some activity with GSSG can be detected. 1.5fold decrease in turnover-number for trypanothione, 9.5fold decrease in KM-value for trypanothione
A18E/N21W/R22N
-
mutant enzyme shows very little activity with GSSG in micromolar range but, on increasing the GSSG concentration to 20 mM some activity with GSSG can be detected. 1.6fold increase in turnover-number for trypanothione, 3fold decrease in KM-value for trypanothione
A18E/N21W/R22N/N101D/K105D
-
mutant enzyme shows very little activity with GSSG in micromolar range but, on increasing the GSSG concentration to 20 mM some activity with GSSG can be detected. 1.5fold increase in turnover-number for trypanothione, 6.7fold decrease in KM-value for trypanothione
N101D/K105D
-
about 2fold increase in KM-value for GSSG, 1.2fold decrease in turnover-number. 1.6fold decrease in turnover-number for trypanothione, 1.15fold increase in KM-value for trypanothione
N21R
-
1.6fold increase in KM-value for GSSG, 1.4fold decrease in turnover-number for GSSG, 1.2fold decrease in turnover-number for trypanothione, 2.3fold increase in turnover number for trypanothione
A34E/R37W
-
glutathione reductase mutant, activity switches to trypanothione reductase, termed GRTR, 700fold more activity with trypanothione than with glutathione
additional information
Renatured/COMMENTARY
ORGANISM
UNIPROT
LITERATURE
refolding after treatment with 6 M urea, recovering of full activity
-
APPLICATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
medicine
pharmacology
-
enzyme is a target for enzyme inhibitor and antimalarial drug development
Show AA Sequence (2788 entries)
Please use the Sequence Search for a specific query.